XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), net of tax
Accumulated Deficit
Balance at Dec. 31, 2021 $ 34,316 $ 13 $ 227,700   $ (193,397)
Balance, Shares at Dec. 31, 2021   13,007,178      
Exercise of common stock options 8   8    
Exercise of common stock options, Shares   2,718      
Stock-based compensation 844   844    
Net loss (11,911)       (11,911)
Balance at Mar. 31, 2022 23,257 $ 13 228,552   (205,308)
Balance, Shares at Mar. 31, 2022   13,009,896      
Balance at Dec. 31, 2021 34,316 $ 13 227,700   (193,397)
Balance, Shares at Dec. 31, 2021   13,007,178      
Net loss (41,043)        
Balance at Sep. 30, 2022 93,222 $ 32 327,630   (234,440)
Balance, Shares at Sep. 30, 2022   31,827,008      
Balance at Mar. 31, 2022 23,257 $ 13 228,552   (205,308)
Balance, Shares at Mar. 31, 2022   13,009,896      
Issuance of common stock and pre-fundedwarrants, net of issuance costs 96,251 $ 19 96,232    
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares   18,815,159      
Issuance of common stock upon RSU vesting, shares   1,302      
Stock-based compensation 1,107   1,107    
Net loss (14,366)       (14,366)
Balance at Jun. 30, 2022 106,249 $ 32 325,891   (219,674)
Balance, Shares at Jun. 30, 2022   31,826,357      
Issuance of common stock upon RSU vesting, shares   651      
Stock-based compensation 1,739   1,739    
Net loss (14,766)       (14,766)
Balance at Sep. 30, 2022 93,222 $ 32 327,630   (234,440)
Balance, Shares at Sep. 30, 2022   31,827,008      
Balance at Dec. 31, 2022 80,754 $ 32 329,387 $ 10 (248,675)
Balance, Shares at Dec. 31, 2022   31,827,659      
Issuance of common stock upon RSU vesting, shares   7,041      
Exercise of common stock options 4   4    
Exercise of common stock options, Shares   2,115      
Unrealized loss on available-for-sale securities (22)     (22)  
Stock-based compensation 1,610   1,610    
Net loss (16,255)       (16,255)
Balance at Mar. 31, 2023 66,091 $ 32 331,001 (12) (264,930)
Balance, Shares at Mar. 31, 2023   31,836,815      
Balance at Dec. 31, 2022 $ 80,754 $ 32 329,387 10 (248,675)
Balance, Shares at Dec. 31, 2022   31,827,659      
Exercise of common stock options, Shares 57,897        
Net loss $ (47,524)        
Balance at Sep. 30, 2023 84,239 $ 50 380,395 (7) (296,199)
Balance, Shares at Sep. 30, 2023   49,545,559      
Balance at Mar. 31, 2023 66,091 $ 32 331,001 (12) (264,930)
Balance, Shares at Mar. 31, 2023   31,836,815      
Issuance of common stock and pre-fundedwarrants, net of issuance costs 46,668 $ 18 46,650    
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares   17,652,962      
Exercise of common stock options 97   97    
Exercise of common stock options, Shares   55,262      
Unrealized loss on available-for-sale securities (15)     (15)  
Stock-based compensation 1,354   1,354    
Net loss (15,618)       (15,618)
Balance at Jun. 30, 2023 98,577 $ 50 379,102 (27) (280,548)
Balance, Shares at Jun. 30, 2023   49,545,039      
Issuance costs (150)   (150)    
Exercise of common stock options 2   2    
Exercise of common stock options, Shares   520      
Unrealized gain on available-for-sale securities 20     20  
Stock-based compensation 1,441   1,441    
Net loss (15,651)        
Balance at Sep. 30, 2023 $ 84,239 $ 50 $ 380,395 $ (7) $ (296,199)
Balance, Shares at Sep. 30, 2023   49,545,559